Clinical Trial Update: Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating neratinib in combination with capecitabine in solid tumors and breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• neratinib + capecitabine

Snippet

Sponsor: Puma Biotechnology, Inc. | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-11-09